Health & Biotech
Health Check: It’s sale time as Medadvisor mulls Aussie exit and Althea renounces medicinal cannabis
Cardiex lodges TGA application for arterial health monitor
Meds are getting cooked and tested in orbit, and an ASX stock is part of the action
Biocurious: With psychedelic therapies gaining cred, Tryptamine offers patients and investors the trip of a lifetime
Dimerix banks upfront US$30m payment in US pharma licensing deal for kidney drug
Health Check: Investors catch a falling knife as biotech big names bounce from lows
EBR Systems applies for cardiac device reimbursement for outpatients
Neurotech’s NTI164 shows excellent tolerability in key preclinical toxicology studies
Neurizon’s NUZ-001 trial reveals heightened survival rate for patients with ALS
Health Check: Biotechs recover as peace descends on the FDA – for now
ASX health April winners: Sector rises 2pc in stronger month for markets
Race Oncology doses first patient in RC220 Phase 1 solid tumour trial
ASX Health Quarterly Wrap: Island completes Phase 2a/b dengue trial
Dimerix inks lucrative US licensing deal for phase III drug candidate
Health Check: Dimerix shares soar as the company hooks the billion-dollar big one in the US
Dr Boreham’s Crucible: The Aussie drug company giving thanks for US health sector mayhem
ASX Health Quarterly Wrap: Control Bionics reports strong US revenue, LTR Pharma makes FDA progress
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
